12 09, 2024

Qkine collaboration with the Bertero Lab, Heart Engineering and Developmental Genomics et al. (HEDGe), University of Turin, Italy

2024-09-12T11:52:48+00:00September 12th, 2024|Blog, News, stem cells|

This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.

30 08, 2024

The transformative power of hematopoietic stem cells in medicine

2024-08-30T08:33:32+00:00August 30th, 2024|Blog, Hematopoietic, stem cells|

Hematopoietic stem cells (HSCs) are at the forefront of a transformative shift in modern medicine, beginning to revolutionize patient care by offering novel therapeutic treatments for a wide range of diseases. This review blog summarizes advances in the clinical use of HSCs in HSC transplantation.

14 08, 2024

ISSCR 2024: scientists and suppliers working together will improve the future of stem cell research

2024-10-10T08:22:00+00:00August 14th, 2024|animal-free, Blog, Event, News, stem cells|

Qkine is a company run by scientists, and the science is the focus of everything we do.Our theme at ISSCR this year was stress-free stem cell culture - exploring how suppliers of recombinant proteins can proactively improve the quality, availability and functionality of growth factors to generate experimental outcomes faster, easier and more efficiently.We discussed priorities for the stem cell science supply chain with scientists from academic and industry labs and had in-depth conversations about the impact of growth factors and cytokines quality on reproducibility and how to integrate new technologies, such as controlled-release and thermostable proteins, to improve the scalability of expansion and differentiation protocols.Through collaboration, we learn and, together, improve the future of stem cell research.

24 07, 2024

ISSCR 2024 reflections on “Standards for Human Stem Cell Use in Research” and growth factors for cell therapy manufacture

2024-07-25T16:45:56+00:00July 24th, 2024|animal-free, Blog, News, protein science, quality, Resources, stem cells|

Reflections on the dynamic ISSCR 2024 workshop on Standards for Human Stem Cell Use in Research including recommendations for growth factor supply chains for raw (ancillary materials) for cell therapy and ATMP manufacture.

9 07, 2024

Qkine and StemCultures collaborate to provide new solutions for precision stem cell culture

2024-07-09T16:09:20+00:00July 9th, 2024|animal-free, Blog, News, Press Release, protein engineering, protein science, quality, Resources, stem cells|

Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.

19 09, 2023

Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus

2023-09-26T07:53:25+00:00September 19th, 2023|News, Press Release, stem cells|

Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus

Go to Top